About ESAC
ESAC is a Healthcare company based in Rockville (United States) founded in 2000, and was acquired by ICF in November 2021. Bioinformatics tools are provided for research and clinical applications. The company has 36 employees. ESAC offers products and services including Health IT Solutions, Software Development, and Data Analytics. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is ESAC INC. Its competitors include Genuity Science, Cellworks and Codetta; 3 of its 3 listed competitors have raised funding.
Company details
ESAC was founded in 2000 and is headquartered in Rockville, United States. Operations focus on the bioinformatics and healthcare information technology sectors. Services include research data management, genomics and proteomics analysis, big data integration, and data coordination solutions. These are delivered to government, commercial, and academic clients across various applications.
- Headquarters Rockville, United States
- Employees 36
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website esacinc.com
- Social LinkedIn X
- Acquired by ICF (Nov 2021)
- Legal Name Esac Inc
Products & Services of ESAC
ESAC offers a comprehensive portfolio of products and services, including Health IT Solutions, Software Development, and Data Analytics.
Offers data integration and analytics for health programs
Provides systems for federal health information exchange
Delivers insights from large-scale data sets for research
Investors in ESAC
ESAC has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ICF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
IT suite and market research services are provided worldwide. | 1969 | icf.com | United States |
Investor details for ESAC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ESAC
2 dated milestones of ESAC across 21 years, from founding to its latest funding, stage changes and deals.
- Founded ESAC is founded.
- Exit Acquired by ICF.
Competitors of ESAC
ESAC has 3 listed competitors in our database, 3 of them funded. They include Genuity Science, Cellworks and Codetta.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. | ||
| cellworks.life | 2005 | San Jose, United States | $16.52M | Biosimulation platform developed for therapeutic design in life sciences. | ||
| codettabio.com | 2021 | Morrisville, United States | $27.28M | Omics clinical data is analyzed through an online platform. |
Detailed competitors of ESAC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ESAC (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Esac
Complete news archive for ESAC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ESAC
ESAC was founded in 2000.
ESAC is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
ESAC has 36 employees.
ESAC was founded in 2000 and is headquartered in Rockville, United States. Operations focus on the bioinformatics and healthcare information technology sectors. Services include research data management, genomics and proteomics analysis, big data integration, and data coordination solutions. These are delivered to government, commercial, and academic clients across various applications.
ESAC's top competitors include Cellworks, Codetta and Genuity Science.
ESAC offers Health IT Solutions, Software Development, and Data Analytics.
ESAC has 1 investor. Key investors include ICF.
ESAC operates through Esac Inc.
Yes. ESAC was acquired by ICF in November 2021.